Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: ispor annual 2019 rti hs presentations
… Earnshaw, PhD, Senior Vice President, Health Economics at RTI Health Solutions (RTI-HS) on being named a North Carolina State University (NCSU) …
… PhD, is Senior Vice President of Health Economics at RTI-HS. She was trained in industrial engineering/operations … programming methods. In addition to teaching the ISPOR budget impact short courses, she presents the Markov …
… Assigning Treatment Strategy Share on: August 22, 2019 A Challenge of Real World Data: How to Assign … Albeniz Martinez , MD, PhD Senior Research Epidemiologist RTI Health Solutions Transcript: When using observational …
… Collaboration Working at RTI-HS is different—meaningful, highly professional and motivated … in multidisciplinary, integrated teams is a big asset of RTI-HS and makes us unique. For example, after a client call …
… is an Executive Director in the Health Economics group at RTI-HS with a strong interest and extensive background in … Society of Pharmacoeconomics and Outcomes Research (ISPOR) and the ISPOR Open-Source Models Special Interest …
… Miles, MS, is an Associate Director of Health Economics at RTI-HS. Her primary area of expertise is the development of … Society of Pharmacoeconomics and Outcomes Research (ISPOR). Ms. Miles is experienced in a variety of therapeutic …
… VA Brian Samsell, PhD, is a Manager, Medical Writing at RTI-HS, where he leads a team of medical writers who collaborate … category and was presented at the podium during Spring 2019 SAWC. He has also co-authored a book chapter on …
… Economist in the Health Preference Assessment group at RTI-HS. He assists in creating surveys and analyzing data in … Degree in Mathematics with an minor in Economics in 2019, and a Master’s Degree in Agricultural Economics in …
… as aspirin or clopidogrel. In this observational study, RTI Health Solutions collaborated with research institutions … measures in 2013. After labeling changes, the annual prevalence of cilostazol decreased in all the study …
… their treatment compared with standard of care on the annual rate of decline in kidney function over a longer …